GI & Endoscopy

Covidien Releases Clinical Trial Results Supporting the Use of Endoscopic Ablation Therapy as Barrett’s Esophagus Treatment

Covidien, Mansfield, Mass.-based healthcare products company, has announced the results of a clinical trial designed to test the efficacy of its Barrx RF Ablation System as a Barrett’s esophagus treatment.

Carrie Pallardy

Wednesday, May 22nd, 2013

The randomized, prospective, multicenter, controlled trial involved 136 Barrett’s esophagus patients with low-grade dysplasia. After the last endoscopy visit, 90 percent of the patients treated with ablation demonstrated no signs of Barrett’s esophagus tissue.

More Articles on Gastroenterology:
8 Trends Shaping the Present & Future of Gastroenterology
PENTAX Launches Video Processor With PENTAX i-SCAN
Vision-Sciences Names Howard Zauberman Interim CEO

Next Up in GI & Endoscopy

5 GI leaders honored in 2025

In 2025, national gastroenterology and hepatology organizations recognized physicians whose work is advancing digestive disease research, clinical care, education and…

By: Sophie Eydis
Yesterday
The 5 highest-paid gastroenterologists in Miami

The highest-paid gastroenterologist in Miami earns $979,100 per year, according to Medscape’s salary reporter tool. Here is what the five…

By: Cameron Cortigiano
2 days ago
Gastroenterologist named chair of MetroHealth department of medicine

Cleveland-based MetroHealth System has appointed John Vargo, MD, as chair of its department of medicine, according to a Dec. 15…

By: Patsy Newitt
2 days ago

Comments are closed.

RCM trend report: How leaders can protect revenue + adapt to disruption

Next Up in GI & Endoscopy

5 GI leaders honored in 2025

The 5 highest-paid gastroenterologists in Miami

Gastroenterologist named chair of MetroHealth department of medicine

Join the 40,000+ ASC leaders who start their day with Becker's